论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y
Received 4 March 2019
Accepted for publication 10 April 2019
Published 13 May 2019 Volume 2019:12 Pages 3619—3624
DOI https://doi.org/10.2147/OTT.S207546
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Aruna Narula
Peer reviewer comments 2
Editor who approved publication: Dr Leo Jen-Liang Su
Abstract: In the
human intestinal tract, there are more than 100 trillion symbiotic bacteria,
which form the gut microbiota. Approximately 70% of the human immune system is
in the intestinal tract, which prevents infection by pathogenic bacteria. When
the intestinal microbiota is disturbed, causing dysbiosis, it can lead to
obesity, diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis,
multiple sclerosis, autism spectrum disorder and cancer. Recent metabolomics
analyses have also made the association between the microbiota and
carcinogenesis clear. Here, we review the current evidence on the association
between the microbiota and gastric, bladder, hepatobiliary, pancreatic, lung
and colorectal cancer. Moreover, several animal studies have revealed that
probiotics seem to be effective for the prevention of carcinogenesis to some
extent. In this review, we focused on this relationship between the microbiota
and cancer, and considered how to prevent cancer using strategies involving the
gut microbiota.
Keywords: dysbiosis,
prebiotics, probiotics, antibiotics
